Answer
Clarithromycin, a strong CYP3A4 inhibitor given orally at 500 mg twice daily for 7 days, caused no clinically significant differences in selinexor pharmacokinetics when co-administered.
Sources for this answer
- NexpovioMenarini Stemline UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked